US Congress Senate Bill 2282 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on November 16 2015 - 25% progression, died in committee
Action: 2015-11-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Stem Cell Therapeutic and Research Reauthorization Act of 2015 This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.) The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised. HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.

Stem Cell Therapeutic and Research Reauthorization Act of 2015

Sen. Orrin Hatch [R-UT]	Sen. Jack Reed [D-RI]	Sen. Richard Burr [R-NC]	Sen. Al Franken [D-MN]
Sen. Lamar Alexander [R-TN]

Date	Chamber	Action
2015-11-16	Senate	Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)

HB2820 (Related) 2015-12-18 - Became Public Law No: 114-104. (TXT | PDF)

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/senate-bill/2282/all-info
Text	https://www.congress.gov/114/bills/s2282/BILLS-114s2282is.pdf